Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TipRanksNov 25 20:46 · Ratings

GSK Cancer Therapy Candidate Accepted for FDA Review

MT NewswiresNov 25 20:03

Blenrep Combinations Accepted for Review by the US FDA for the Treatment of Relapsed/refractory Multiple Myeloma

GSK PlcNov 25 13:00

Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC

Seeking AlphaNov 23 10:25

GSK's RSV Vaccine Approved for Japanese Patients in Their 50s

MT NewswiresNov 22 20:05

Arexvy Approval Expanded to Adults Aged 50-59 at Increased Risk of Severe RSV Disease in Japan

GSK PlcNov 22 13:00